Stocks pullback after Tuesday rally 📉

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Today is Wednesday, October 25th. I hope you had a great trading session. Here's what moved the market today: Markets 📈 Stocks turned south on Wednesday, with most large-cap indexes erasing their previous-day gains. The Dow [-0.3%] fared the best with the smallest loss, while the S&P 500 [-1.4%] and Nasdaq [-2.4%] sold off for steep losses, alongside the small-cap Russell 2K [-1.6%]. Sponsored [This DeFi Coin Could 10x Soon... I Advise You Get In Now!]( I'm urging all of my followers - do NOT miss this opportunity for life-changing gains this year. Experts are predicting this coin has potential for unprecedented growth. Even a small position could deliver 10x returns or greater very soon. Timing is everything. [Go here now to discover this DeFi diamond before the next surge!]( Today's Market-Moving News 🔎 ❌ Nasdaq Rally Gets Corrected Ring the alarm bells, the tech-centered Nasdaq Composite is teetering on the edge of a correction, defined as a 10% dip from its recent peak. Crunching the Numbers 🧮 The index closed at 12,821.22 and officially entered correction territory on Wednesday. For context, the Nasdaq closed at a cushy 14,358.02 on July 19. Why Should You Care? 🤷‍♀️ Corrections are often seen as a warning sign or, more optimistically, a healthy reset. Either way, it’s a notable shift, especially for an index heavily weighted in tech stocks that have been market darlings for so long. The Takeaway 🥡 Market jitters are real, and when a major index like the Nasdaq hints at a correction, everyone from Wall Street to your next-door neighbor takes notice. Eyes are peeled on where it closes, so keep your finger on the pulse. Today's Top Winners and Losers 🔥 reAlpha Tech [AIRE] $60.59 (39.4%) continued to slide after making its Nasdaq debut on Monday. Forbion European SPAC [FRBN] $12.01 (34.0%) said shareholders approved its merger with enGene Holdings in an 8-K filing published Tuesday evening. Sonnet BioTherapeutics [SONN] $1.29 (28.7%) priced a $4.55 million public offering of its common stock at $1.60 per share. Cassava Sciences [SAVA] $18.58 (+25.8%) said MRI data shows that its simufilam drug candidate is not associated with amyloid-related imaging abnormalities discovered in a Phase 3 clinical trial in Alzheimer's patients. Abri SPAC I [ASPA] $27.05 (+114.6%) published a Form 425 notifying the market that shareholders had voted to approve its proposed business combination. BioXcel Therapeutics [BTAI] $2.83 (+20.9%) said results from a single-site TRANQUILITY Phase 3 trial may support a new drug application for BXCL501 for Alzheimer's disease. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... Text ELITE to 47121 to get our watchlists sent directly to your phone! You can also text CLOSE to 47121 to get the Closing Bell Roundup, too! *Standard message/carrier rates may apply. © Elite Trade Media LLC, 2023. All rights reserved. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Bots click here]( 1969 Alafaya Trail Suite #247 Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](